Manzano GS - Search Results

1

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort.

Manzano GS, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Levy M, Matiello M. Manzano GS, et al. Front Neurol. 2022 Jun 20;13:947630. doi: 10.3389/fneur.2022.947630. eCollection 2022. Front Neurol. 2022. PMID: 35795797 Free PMC article.

2

Update on neuromyelitis optica spectrum disorder.

Holroyd KB, Manzano GS, Levy M. Holroyd KB, et al. Among authors: manzano gs. Curr Opin Ophthalmol. 2020 Nov;31(6):462-468. doi: 10.1097/ICU.0000000000000703. Curr Opin Ophthalmol. 2020. PMID: 33009077 Free PMC article. Review.

3

Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis.

Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Manzano GS, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 27;8(6):e1080. doi: 10.1212/NXI.0000000000001080. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34452974 Free PMC article.

4

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.

Manzano GS, Rice DR, Klawiter EC, Matiello M, Gillani RL, Tauhid SS, Bakshi R, Mateen FJ. Manzano GS, et al. Mult Scler. 2022 Jun;28(7):1146-1150. doi: 10.1177/13524585221092309. Epub 2022 Apr 27. Mult Scler. 2022. PMID: 35475382

5

Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series.

Manzano GS, Holroyd KB, Kaplan T, Bhattacharyya S, Chitnis T, Hotan G, Zurawski J, Galetta KM, Mateen FJ. Manzano GS, et al. Mult Scler Relat Disord. 2022 Jul;63:103861. doi: 10.1016/j.msard.2022.103861. Epub 2022 May 10. Mult Scler Relat Disord. 2022. PMID: 35576727

6

Treatment outcomes of first-ever episode of severe optic neuritis.

Galetta K, Ryan S, Manzano G, Chibnik LB, Balaban D, Prasad S, Chwalisz BK, Salazar-Camelo A, Conway S, Levy M, Matiello M. Galetta K, et al. Mult Scler Relat Disord. 2022 Oct;66:104020. doi: 10.1016/j.msard.2022.104020. Epub 2022 Jul 2. Mult Scler Relat Disord. 2022. PMID: 35839615 Review.

7

COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Lotan I, Nishiyama S, Manzano GS, Lydston M, Levy M. Lotan I, et al. Among authors: manzano gs. Front Neurol. 2022 Sep 20;13:970383. doi: 10.3389/fneur.2022.970383. eCollection 2022. Front Neurol. 2022. PMID: 36203986 Free PMC article.

8

Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report.

Manzano GS, Rice DR, Zurawski J, Jalkh Y, Bakshi R, Mateen FJ. Manzano GS, et al. J Neuroimmunol. 2023 Jun 15;379:578099. doi: 10.1016/j.jneuroim.2023.578099. Epub 2023 May 5. J Neuroimmunol. 2023. PMID: 37172371

9

Safety and Feasibility of an Emergency Department-to-Outpatient Pathway for Patients With TIA and Nondisabling Stroke.

Roy A, Sreekrishnan A, Camargo Faye E, Silverman S, Zachrison KS, Harriott AM, Matiello M, Manzano GS, Prasanna M, Nedelcu S, Singhal AB. Roy A, et al. Among authors: manzano gs. Neurol Clin Pract. 2023 Dec;13(6):e200209. doi: 10.1212/CPJ.0000000000200209. Epub 2023 Oct 11. Neurol Clin Pract. 2023. PMID: 37829551

10

Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes.

Manzano GS, Levy M, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Vasileiou ES, Sotirchos ES, Gibbons E, Huda S, Jacob A, Matiello M. Manzano GS, et al. J Neurol. 2024 Sep;271(9):6160-6171. doi: 10.1007/s00415-024-12585-w. Epub 2024 Jul 27. J Neurol. 2024. PMID: 39066792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters